SVP, Head of Business Development, BMS
Paul Biondi is currently SVP, Head of Business Development reporting to Charlie Bancroft, EVP and Chief Financial Officer.
As head of Business Development, Paul leads the development of strategic partnerships and pursues external scientific innovations across commercial, development, discovery and technology platforms to complement the company’s internal R&D pipeline. With deep knowledge of the company’s R&D strategy and portfolio, strong business expertise and understanding of the healthcare landscape, Paul is focused on external innovation that helps Bristol-Myers Squibb develop and deliver transformational medicines for patients with serious diseases.
Prior to this recent appointment, Paul led the R&D Operations organization for 10 years providing strategic insights and operations excellence to enhance the performance of the R&D organization. As head of R&D Operations, he was responsible for optimizing the delivery of the company’s pipeline, managing the company’s R&D portfolio and delivering early- and late-stage clinical operations. He also had responsibility for cross R&D efforts around strategy, analytics, continuous improvement, learning and collaboration. In this role, Paul worked closely with the Business Development leaders in formulating portfolio and disease specific strategies as well as overseeing all integrations of any scientific assets or R&D companies.
Biondi joined Bristol-Myers Squibb in 2002 and was appointed vice president of R&D Operations when it was formed in May 2005. He was promoted to senior vice president of R&D Operations in 2010. Paul was appointed SVP, Head of Business Development in October 2015.
Biondi holds a bachelor’s degree in government and economics from Dartmouth College and an M.B.A. from J.L. Kellogg School of Management at Northwestern University.